Here, we identified a previously uncharacterized polypeptide, N1DARP, encoded by LINC00261, through RNA sequencing and ribosome profiling, as a novel tumor suppressor and chemotherapy sensitizer for use in pancreatic cancer therapy, which acts by interfering with USP10–N1ICD interaction. Here, LINC00261 is linked to neoplasm.